Harry has extensive experience working with start-up companies in particular in the healthcare sector.

He has been involved in the medicinal cannabis sector since 2014 and has been involved as a Founding Director/Shareholder of several of Australia’s leading medicinal cannabis companies including the ASX-listed companies AusCann Group Holdings Ltd (founding Director), Zelda Therapeutics Ltd (Chairman) and CannPal Animal Therapeutics Ltd (founding shareholder).Harry graduated from the University of Western Australia with a Bachelor of Science (Hons) majoring in Biochemistry and Microbiology and a Master of Business Administration (MBA). He is also a Fellow of the Financial Services Institute of Australia, a Fellow of the Australian Institute of Company Directors and has qualified as a Chartered Financial Analyst (CFA) from the CFA Institute in the United States.

< BACK TO TEAM

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close